Paper 70 - IS 5 THE NEW 25 YET? UPDATED 5-YEAR OUTCOMES FROM A PROSPECTIVE PHASE II TRIAL OF NEOADJUVANT ULTRA-HYPOFRACTIONATED RADIATION FOR EXTREMITY AND TRUNK SOFT TISSUE SARCOMA

Author(s)

• 

  Alexandra C. Istl, MD, MPH (she/her/hers)

  Assistant Professor
  Medical College of Wisconsin
  milwaukee, Wisconsin, United States

  Slides

Co-Author(s)

• MC

  Meghan Conroy, MD MPH

  MCW
  Milwaukee, Wisconsin, United States
• 

  John Charlson, MD (he/him/his)

  Associate Professor
  Medical College of Wisconsin
  Milwaukee, Wisconsin, United States
• AW

  Adam Wooldridge, MD MPH

  MCW
  Milwaukee, Wisconsin, United States
• JN

  John C Neilson, MD

  Division Director Orthopaedic Oncology
  MCW
  Milwaukee, Wisconsin, United States
• 

  David M. King, MD

  Professor and Chair Department of Orthopaedic Surgery
  MCW
  Milwaukee WI, Wisconsin, United States
• DH

  Donald Hackbarth, Jr., MD

  MCW
  Milwaukee, Wisconsin, United States
• 

  Meena Bedi, MD MS

  Associate Professor of Radiation Oncology
  MCW
  Milwaukee, Wisconsin, United States